Ferring Reviews Operations, Considers Job Cuts in Switzerland
Ferring Pharmaceuticals is reviewing its operations, considering geographical relocation of certain positions to improve business efficiency. The company is currently in consultations with social partners in Switzerland, where it employs over 730 people in St-Prex. No specific figures on job cuts in Switzerland have been released yet.
Ferring Pharmaceuticals, a global pharmaceutical company with over 7500 employees in more than 50 countries, is in the midst of these changes. In Switzerland, the company is consulting with social partners about potential job cuts. The St-Prex site, which employs 730 staff, is one of the locations under review. The company has announced that the proposed changes could lead to a worldwide reduction of up to 500 jobs. Employees at the affected sites have been informed of these proposals.
Ferring Pharmaceuticals is in the process of reviewing its operations, with potential job cuts affecting up to 500 positions worldwide. The company is currently in consultations with social partners in Switzerland, where it has a significant presence. The outcome of these changes is still under discussion, with no specific figures released for Switzerland yet.
